PHR
Phreesia, Inc. NYSE Listed Jul 18, 2019$9.84
Mkt Cap $597.6M
52w Low $7.77
8.3% of range
52w High $32.76
50d MA $10.32
200d MA $18.54
P/E (TTM)
250.5x
EV/EBITDA
28.2x
P/B
1.7x
Debt/Equity
0.3x
ROE
0.7%
P/FCF
11.8x
RSI (14)
—
ATR (14)
—
Beta
0.85
50d MA
$10.32
200d MA
$18.54
Avg Volume
2.2M
About
Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. Its Phreesia Platform offers a suite of solutions to manage the patient intake process, as well as an integrated payments solution for processing of patient payments. The company deploys its platform in a range of modalities, such as Phreesia Mobile, a patient…
Recent Earnings
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 30, 2026 | AMC | 0.07 | 0.12 | +82.6% | 11.41 | -29.7% | -26.6% | -26.4% | -26.6% | -19.8% | -20.6% | — |
| Dec 8, 2025 | AMC | -0.00 | 0.10 | +9999.0% | 20.12 | -4.7% | -23.3% | -21.6% | -20.3% | -19.2% | -17.0% | — |
| Sep 4, 2025 | AMC | -0.07 | 0.01 | +114.3% | 31.21 | -7.1% | -9.9% | -14.2% | -14.9% | -18.8% | -18.4% | — |
| May 28, 2025 | AMC | -0.13 | -0.07 | +46.2% | 23.30 | +2.7% | +4.8% | +5.1% | +6.9% | +10.6% | +8.2% | — |
| Mar 12, 2025 | AMC | -0.19 | -0.11 | +42.1% | 23.80 | +1.0% | +6.9% | +6.9% | +13.2% | +14.6% | +21.8% | — |
| Dec 9, 2024 | AMC | -0.27 | -0.25 | +7.4% | 21.63 | +2.7% | +11.6% | +14.6% | +13.5% | +15.3% | +18.5% | — |
| Sep 4, 2024 | AMC | -0.37 | -0.31 | +16.2% | 24.17 | +1.4% | +6.3% | -2.6% | -1.1% | -2.2% | -3.5% | — |
| May 30, 2024 | AMC | -0.51 | -0.35 | +31.4% | 21.31 | -3.7% | -11.2% | -13.0% | -12.6% | -7.8% | -7.3% | — |
| Mar 14, 2024 | AMC | -0.58 | -0.56 | +3.4% | 22.67 | +3.6% | +4.8% | +1.2% | +2.2% | +6.8% | +4.0% | — |
| Dec 5, 2023 | AMC | -0.72 | -0.58 | +19.4% | 14.75 | +23.1% | +21.2% | +21.2% | +22.3% | +27.2% | +35.7% | — |
Recent Analyst Ratings
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 13 | KeyBanc Capital Markets | Maintains | Overweight → Overweight | — | $8.06 | $8.03 | -0.4% | +6.2% | +6.7% | +12.4% | +13.8% | +13.8% |
| Apr 1 | Citizens | Downgrade | Market Outperform → Market Perform | — | $8.38 | $8.40 | +0.2% | +0.2% | -0.1% | +9.2% | +8.1% | +4.4% |
| Mar 31 | Truist | Downgrade | Buy → Hold | — | $11.41 | $8.02 | -29.7% | -26.6% | -26.4% | -26.6% | -19.8% | -20.6% |
| Mar 31 | Needham | Maintains | Buy → Buy | — | $11.41 | $8.02 | -29.7% | -26.6% | -26.4% | -26.6% | -19.8% | -20.6% |
| Mar 31 | Canaccord Genuity | Maintains | Buy → Buy | — | $11.41 | $8.02 | -29.7% | -26.6% | -26.4% | -26.6% | -19.8% | -20.6% |
| Mar 31 | BMO Capital | Maintains | Outperform → Outperform | — | $11.41 | $8.02 | -29.7% | -26.6% | -26.4% | -26.6% | -19.8% | -20.6% |
| Mar 31 | Baird | Downgrade | Outperform → Neutral | — | $11.41 | $8.02 | -29.7% | -26.6% | -26.4% | -26.6% | -19.8% | -20.6% |
| Mar 31 | Citigroup | Downgrade | Buy → Neutral | — | $11.41 | $8.02 | -29.7% | -26.6% | -26.4% | -26.6% | -19.8% | -20.6% |
| Mar 31 | Stephens & Co. | Maintains | Overweight → Overweight | — | $11.41 | $8.02 | -29.7% | -26.6% | -26.4% | -26.6% | -19.8% | -20.6% |
| Mar 31 | JP Morgan | Downgrade | Overweight → Neutral | — | $11.41 | $8.02 | -29.7% | -26.6% | -26.4% | -26.6% | -19.8% | -20.6% |
Recent Filings
8-K · 1.01
!! High
Phreesia, Inc. -- 8-K 1.01: Material Agreement
Phreesia secured financing through PNC Bank via an amended credit facility for its AccessOne MedCard subsidiary, expanding its financial flexibility for healthcare payment solutions operations.
May 4
8-K
Unknown — 8-K Filing
I cannot provide a meaningful analysis as the excerpt only contains boilerplate forward-looking statement disclaimers with no substantive business information about PHR's actual events or developments.
Apr 3
8-K
Unknown — 8-K Filing
Phreesia reported Q4 FY2026 results showing its all-remote operating model, which could indicate higher margins and talent flexibility, potentially supporting profitability and growth investors should monitor in future quarters.
Mar 30
8-K · 1.01
! Medium
Unknown — 8-K 1.01: Financing / Debt Agreement
The company refinanced existing debt with Goldman Sachs and Capital One, potentially improving terms or extending maturity dates, which could reduce near-term financial pressure and refinancing risk.
Mar 16
8-K · 5.02
!!! Very High
Phreesia, Inc. -- 8-K 5.02: Executive Change
Phreesia is replacing two directors with Jon Kessler, signaling potential leadership evolution as Edward Cahill and Michael Weintraub exit the board effective April 2026.
Feb 23
Data updated apr 26, 2026 7:37pm
· Source: massive.com